Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Akari, Deciphera Both Nab $75 Million in Financing

NEW YORK — Deciphera Pharmaceuticals and Akari Therapeutics both secured $75 million in funding, which will be used to advance the pipelines of both companies, the companies said in separate statements this morning.   Akari said the $75 million it raised will be used to advance the company’s lead product Coversin, a C5 complement inhibitor, […]

Read More »

Bay Area’s ZS Pharma Jumps on Merger Talks, Actelion Stock Drops

Switzerland-based Actelion Ltd. (ALIOF.PK) last week confirmed that it was in talks to acquire ZA Pharma Inc. As a result, the stock dropped about 3.2 percent overnight. ZS Pharma (ZSPH), headquartered in Mateo, Calif., found its stock price jumping 28 percent.   Actelion focuses on pulmonary arterial hypertension (PAH) and markets Veletri, Tracleer and Opsumit. […]

Read More »

McKesson Corporation to Acquire UDG Healthcare’s Pharma Distribution Division for $466 Million

McKesson Announces Agreement to Purchase the Pharmaceutical Distribution Division of UDG Healthcare plc • McKesson to acquire the pharmaceutical distribution division of UDG Healthcare plc for €408 million in cash. • Acquisition will add a leader in pharmaceutical distribution across the Republic of Ireland and Northern Ireland to McKesson’s European business. • The acquisition is […]

Read More »

Novartis hit by China, emerging market slowdown: CEO on CNBC

Drugmaker Novartis has been hit by a slowdown in emerging markets, particularly in China, where previously double-digit growth has decelerated to mid-single digits, Chief Executive Joe Jimenez said in an interview with CNBC on Friday.   Jimenez’ comments echoed concerns expressed on Thursday by U.S. Federal Reserve Chair Janet Yellen, who said the outlook in […]

Read More »

Perrigo recommends shareholders reject Mylan’s tender offer

Generic and over-the-counter drugmaker Perrigo Co on Thursday urged its shareholders to reject Mylan NV’s unsolicited $27 billion tender offer, saying it substantially undervalued the company. Mylan first proposed to buy Perrigo in April and, after being repeatedly rebuffed, launched a tender offer on Monday. It has said it would take control if more than […]

Read More »

Amgen To Acquire Privately Held Dezima Pharma

Strengthens Amgen’s Cardiovascular Portfolio With Late-Stage, Oral CETP Inhibitor   THOUSAND OAKS, Calif. and NAARDEN, Netherlands, Sept. 16, 2015 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Dezima Pharma B.V. (Dezima) today announced that the companies have entered into a definitive acquisition agreement under which Amgen will acquire Dezima, a privately-held, Netherlands-based biotechnology company focused on developing innovative […]

Read More »

Dental supply maker Dentsply to buy Sirona in $5.56 billion deal

Dentsply International Inc (XRAY.O) said on Tuesday it would merge with peer Sirona Dental Systems Inc (SIRO.O) in a $5.56 billion all-stock deal, creating the world’s largest dental equipment maker. The deal will combine Dentsply’s single-use dental supplies, such as paste and sealants, with Sirona’s advanced technology equipment, such as imaging systems and instruments. “There […]

Read More »

Sony, Olympus to unveil high-definition endoscope

Sony Corp and Olympus Corp said they plan to unveil an ultra high-definition surgical endoscope this week, the first major product from a joint venture formed three years ago. The product allows physicians to view clearer, more instant images of internal organs, aiding precision during surgical procedures, the medical device makers told Reuters ahead of […]

Read More »

Mylan Begins Hostile Bid for Perrigo

Mylan NV on Monday officially took its takeover bid directly to shareholders of Perrigo Co. (PRGO 0.88 %) after the company’s board and management publicly rebuffed previous advances.   Mylan is offering $75 in cash and 2.3 shares of Mylan for each Perrigo share held, valued at about $187 based on Friday’s closing price. Perrigo’s shares […]

Read More »

Actelion in talks with ZS Pharma amid surge in biotech deal-making

Swiss drugmaker Actelion Ltd has initiated preliminary discussions with U.S. biotech company ZS Pharma Inc, marking the latest bout of deal-making in a healthcare sector that has seen a wave of recent takeovers. Actelion, Europe’s biggest biotech company, and ZS Pharma both issued statements late on Thursday stating that they had held preliminary discussions, but […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom